SCHEMBL19696803

SCHEMBL19696803

N[C@H](C(=O)O)[C@H](c1ccc(Cl)cc1)c1ccc2c(c1)OCO2

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.47
RAB9A P51151 3/20 0.47
MAPK9 P45984 1/20 0.46
KMT2A Q03164 5/20 0.45
MEN1 O00255 4/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
NPSR1 Q6W5P4 2/20 0.45
TP53 P04637 1/20 0.45
NFKB1 P19838 1/20 0.45
NFKB2 Q00653 1/20 0.45
RELA Q04206 1/20 0.45
OGA O60502 1/20 0.45
MAPT P10636 4/20 0.44
PTGS1 P23219 1/20 0.43
PTGS2 P35354 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
MAOA P21397 1/20 0.43
MAOB P27338 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8874548 0.92 MAPK9 (0.52) MAPK9KMT2AMEN1PTGS1PTGS2
SCHEMBL3740095 0.81 CYP2C9 (0.61) KMT2AMEN1NFKB1PTGS1CYP2D6
SCHEMBL3740089 0.81 CYP2C9 (0.61) KMT2AMEN1NFKB1PTGS1CYP2D6
SCHEMBL5281154 0.80 MAPK9 (0.52) MAPK9KMT2AMEN1PTGS1PTGS2
SCHEMBL16208746 0.79 PTGS1 (0.55) MAPK9KMT2AMEN1PTGS1PTGS2
SCHEMBL5279500 0.79 PTGS1 (0.55) MAPK9KMT2AMEN1PTGS1PTGS2
SCHEMBL7433780 0.79 PTGS1 (0.55) MAPK9KMT2AMEN1PTGS1PTGS2
SCHEMBL15579108 0.78 NPC1 (0.41) NPC1RAB9AMAPK9KMT2AMEN1
SCHEMBL15872468 0.78 NPC1 (0.41) NPC1RAB9AMAPK9KMT2AMEN1
SCHEMBL7684418 0.76 MAPK9 (0.55) MAPK9KMT2AMEN1PTGS1PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9840478-B2 Piperazine derivatives as HIV protease inhibitors MERCK SHARP & DOHME CORP. (US) 2017-12-12 US disclosed